IP Verse

Compositions And Methods For Lowering Triglycerides Without Raising Ldl-C Levels In A Subject On Concomitant Statin Therapy - EP3318255B1

PatentPatent Analysis

EP3318255

AMARIN PHARMACEUTICALS IRELAND
Application Number
EP17187534A
Filing Date
Jun 15, 2010
Status
Revoked
Oct 21, 2022
Grant Date
Mar 10, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3815684B1
EP4056176B1
EP2800469B1

Bibliography

The patent EP3318255B1 was granted to Amarin Pharmaceuticals Ireland on Mar 10, 2021 following the initial filing on Jun 15, 2010 under the application number EP17187534A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

COOKEDec 10, 2021ADMISSIBLE
HOFFMANN EITLEDec 8, 2021ADMISSIBLE
ELKINGTON AND FIFENov 24, 2021ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents